Measurement of Achilles tendon thickness using ultrasonography for diagnosis and risk assessment in patients with familial hypercholesterolemia

Abstract

Familial hypercholesterolemia (FH) is an autosomal dominant inherited disorder characterized by elevated low-density lipoprotein cholesterol (LDL-C) levels and skin and/or tendon xanthomas. FH is caused by mutations in genes associated with the LDL receptor pathway. Heterozygous FH is frequently encountered, occurring in about one in 300 people, one in 30 people with coronary artery disease, and one in 15 people with premature coronary artery disease or severe hyperlipidemia. Because FH patients are exposed to high LDL-C concentrations from birth, this leads to progressive atherosclerosis, and the development of cardiovascular events in these patients is 15-20 years younger than the typical age of onset. Achilles tendon thickening is the most specific physical finding in FH, although it is also observed in patients with metabolic diseases such as sitosterolemia and cerebral tendon xanthomatosis and in cases of Achilles tendon rupture. In Japan, FH criteria include Achilles tendon thickening as a diagnostic criterion in addition to the presence of tendon xanthomas. Furthermore, thicker Achilles tendons are associated with a higher risk of cardiovascular events. Therefore, the measurement of Achilles tendon thickness is beneficial not only for the diagnosis of FH but also for cardiovascular event risk assessment. It is hoped that the measurement of Achilles tendon thickness will improve diagnostic performance and lead to earlier diagnosis and reduced incidence of coronary artery disease. This review summarizes the usefulness of measuring Achilles tendon thickness for diagnosis and risk assessment of cardiovascular events in FH.

Keywords

Familial hypercholesterolemia / Achilles tendon / ultrasonography / radiography / risk assessment

References

[1] Beheshti SO,Varbo A.Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects.J Am Coll Cardiol2020;75:2553-66

[2] Nordestgaard BG,Humphries SE.Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.Eur Heart J2013;34:3478-90 PMCID:PMC3844152

[3] Harada-Shiba M,Ohmura H.Guidelines for the diagnosis and treatment of adult familial hypercholesterolemia 2022.J Atheroscler Thromb2023;30:558-86 PMCID:PMC10164595

[4] Defesche JC,Harada-Shiba M,Santos RD.Familial hypercholesterolaemia.Nat Rev Dis Primers2017;3:17093

[5] Hori M,Son C,Harada-Shiba M.The first Japanese cases of familial hypercholesterolemia due to a known pathogenic APOB gene variant, c.10580 G>A: p.(Arg3527Gln).J Clin Lipidol2020;14:482-6

[6] Hutter CM,Humphries SE.Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview.Am J Epidemiol2004;160:430-5

[7] Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ1991;303:893-6 PMCID:PMC1671226

[8] Williams RR,Schumacher MC.Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics.Am J Cardiol1993;72:171-6

[9] Mabuchi H,Haba T,Ueda R.Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by Achilles' tendon thickness.Atherosclerosis1977;28:61-8

[10] Harada-Shiba M,Ishigaki Y.Guidelines for diagnosis and treatment of familial hypercholesterolemia 2017.J Atheroscler Thromb2018;25:751-70 PMCID:PMC6099072

[11] Tada H,Matsuki K.Achilles tendon thickness assessed by X-ray predicting a pathogenic mutation in familial hypercholesterolemia gene.J Atheroscler Thromb2022;29:816-24 PMCID:PMC9174093

[12] Tada H,Nohara A,Mabuchi H.Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia.Eur Heart J2017;38:1573-9

[13] Michikura M,Ogura M,Harada-Shiba M.The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia.Atherosclerosis2022;358:41-6

[14] Michikura M,Hori M.Association of Achilles tendon thickness with lipid profile and carotid IMT in patients with familial hypercholesterolemia.Atherosclerosis2025;403:119173

[15] Yamamoto A,Yokoyama S,Yamamura T.Effects of probucol on xanthomata regression in familial hypercholesterolemia.Am J Cardiol1986;57:29H-35H

[16] Tsouli SG,Argyropoulou MI,Elisaf M.Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study.Atherosclerosis2009;205:151-5

[17] Bea AM,Marco-Benedi V.Effect of intensive LDL cholesterol lowering with PCSK9 monoclonal antibodies on tendon xanthoma regression in familial hypercholesterolemia.Atherosclerosis2017;263:92-6

[18] Alam L,Fishberg R.Achilles tendon xanthoma thickness and carotid intima-media thickness in a patient with heterozygous familial hypercholesterolemia on PCSK9 inhibition: a case report and literature review.Cureus2020;12:e10497 PMCID:PMC7571593

[19] Munoz-Fernandez AC,Villafane JH.A new ultrasound-guided percutaneous electrolysis and exercise treatment in patellar tendinopathy: three case reports.Front Biosci2021;26:1166-75

[20] Sánchez Romero EA,Martín Pérez S.Lower limb tendinopathy tissue changes assessed through ultrasound: a narrative review.Medicina2020;56:378 PMCID:PMC7466193

[21] Michikura M,Yamamoto M.Achilles tendon ultrasonography for diagnosis of familial hypercholesterolemia among Japanese subjects.Circ J2017;81:1879-85

[22] Harada T,Nagao M.Frequency of achilles tendon Xanthoma in patients with acute coronary syndrome.J Atheroscler Thromb2017;24:949-53 PMCID:PMC5587521

[23] Tada H,Takeji Y,Kawashiri MA.Impact of changes in Achilles tendon thickening on cardiovascular events in patients with familial hypercholesterolemia.Am J Prev Cardiol2024;18:100660 PMCID:PMC10999807

[24] Descamps OS,Van Leuven F.The use of Achilles tendon ultrasonography for the diagnosis of familial hypercholesterolemia.Atherosclerosis2001;157:514-8

[25] Junyent M,Zambón D.The use of Achilles tendon sonography to distinguish familial hypercholesterolemia from other genetic dyslipidemias.Arterioscler Thromb Vasc Biol2005;25:2203-8

[26] Scheel AK,Koziolek M.Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study.Atherosclerosis2004;174:133-9

[27] Sugiyama N,Gown AM,Joffe B.Immunohistochemical distribution of lipoprotein epitopes in xanthomata from patients with familial hypercholesterolemia.Am J Pathol1992;141:99-106 PMCID:PMC1886588

[28] Tall AR,Lees RS.Interaction of collagen with the lipids of tendon xanthomata.J Clin Invest1978;62:836-46 PMCID:PMC371836

[29] Tsouli SG,Lourida ES.Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia.J Lipid Res2006;47:2208-14

[30] Di Pietro N,Pandolfi A.Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis.Vascul Pharmacol2016;84:1-7

[31] Shiels MS,Freedman ND.Cigarette smoking and variations in systemic immune and inflammation markers.J Natl Cancer Inst2014;106:dju294 PMCID:PMC4200029

[32] Arnson Y,Amital H.Effects of tobacco smoke on immunity, inflammation and autoimmunity.J Autoimmun2010;34:J258-65

[33] Kuschner WG,Wong H.Dose-dependent cigarette smoking-related inflammatory responses in healthy adults.Eur Respir J1996;9:1989-94

[34] Nakanishi K,Harada M.Klotho-related molecules upregulated by smoking habit in apparently healthy men: a cross-sectional study.Sci Rep2015;5:14230 PMCID:PMC4585559

[35] Harats D,Dabach Y,Stein O.Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages.Atherosclerosis1989;79:245-52

[36] Valkonen M.Passive smoking induces atherogenic changes in low-density lipoprotein.Circulation1998;97:2012-6

[37] Oosterveer DM,Yazdanpanah M,Kastelein JJ.The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathway.Eur Heart J2010;31:1007-12

[38] Artieda M,Junquera C.Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL.FEBS Lett2005;579:4503-12

[39] Prosenz J,Hadrovic-Avdic M.The twist of the Achilles tendon - associations of torsions in the lower extremity.Clin Anat2018;31:1085-91

[40] Bude RO,Bassett DR.Diagnosis of Achilles tendon xanthoma in patients with heterozygous familial hypercholesterolemia: MR vs sonography.AJR Am J Roentgenol1994;162:913-7

[41] Liem MS,Bloem JL.Magnetic resonance imaging of Achilles tendon xanthomas in familial hypercholesterolemia.Skeletal Radiol1992;21:453-7

[42] Koivunen-Niemelä T,Viikari J.Magnetic resonance imaging of Achilles tendon xanthomas using a fat-water discrimination technique at 0.1 T.Acad Radiol1995;2:319-23

[43] Svendsen K,Vinknes KJ.Risk of stroke in genetically verified familial hypercholesterolemia: a prospective matched cohort study.Atherosclerosis2022;358:34-40

[44] Bujo H,Saito Y.Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan.J Atheroscler Thromb2004;11:146-51

[45] Harada-Shiba M,Arai H.Prevalence of familial hypercholesterolemia in patients with acute coronary syndrome in Japan: results of the EXPLORE-J study.Atherosclerosis2018;277:362-8

[46] Akioyamen LE,Genest J.Risk of ischemic stroke and peripheral Arterial disease in heterozygous familial hypercholesterolemia: a meta-analysis.Angiology2019;70:726-36

[47] Michikura M,Matsuki K,Makino H.Risk assessment for cardiovascular events using achilles tendon thickness and softness and intima-media thickness in familial hypercholesterolemia.J Atheroscler Thromb2024;31:1607-19 PMCID:PMC11537786

[48] Squier K,Hunt MA.The effects of cholesterol accumulation on Achilles tendon biomechanics: a cross-sectional study.PLoS One2021;16:e0257269 PMCID:PMC8445482

[49] Michikura M,Hori M,Hosoda K.Achilles tendon softness as a new tool for diagnosing familial hypercholesterolemia.JACC Cardiovasc Imaging2021;14:1483-5

[50] Michikura M,Hori M.Association between Achilles tendon softness and atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia.J Atheroscler Thromb2022;29:1603-12 PMCID:PMC9623074

[51] Bertolini S,Averna M.Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype.Arterioscler Thromb Vasc Biol2000;20:E41-52

[52] Ogura M,Harada-Shiba M.Association between cholesterol efflux capacity and atherosclerotic cardiovascular disease in patients with familial hypercholesterolemia.Arterioscler Thromb Vasc Biol2016;36:181-8

[53] Tada H,Nohara A,Kawashiri MA.Genetic mutations, regression of Achilles tendon thickness, and cardiovascular events among patients with familial hypercholesterolemia.Atherosclerosis2022;340:28-34

[54] Tsouli SG,Argyropoulou MI,Elisaf MS.Pathogenesis, detection and treatment of Achilles tendon xanthomas.Eur J Clin Invest2005;35:236-44